SCHEMBL3347640

SCHEMBL3347640

O=C(O)C1Oc2c(cc(F)cc2-c2ccccc2C(F)(F)F)S1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.39
AKR1C2 P52895 1/20 0.39
ALDH1A1 P00352 6/20 0.39
HPGD P15428 3/20 0.39
KMO O15229 2/20 0.36
LMNA P02545 3/20 0.35
POLB P06746 2/20 0.35
MAPT P10636 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
GAA P10253 1/20 0.34
SCD5 Q86SK9 1/20 0.34
FFAR1 O14842 2/20 0.33
THRA P10827 1/20 0.33
THRB P10828 1/20 0.33
HTT P42858 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
PSMB8 P28062 1/20 0.33
GPBAR1 Q8TDU6 1/20 0.32
KDM4E B2RXH2 1/20 0.32
SLC9A1 P19634 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3343338 0.80 AKR1C3 (0.32) AKR1C3AKR1C2ALDH1A1HPGDLMNA
SCHEMBL3345385 0.77 HTR2C (0.34) AKR1C3AKR1C2PSMB8
SCHEMBL3347490 0.72 AQP1 (0.33) AKR1C3AKR1C2ALDH1A1THRATHRB
SCHEMBL14194640 0.72
SCHEMBL3341809 0.70 AQP1 (0.40)
SCHEMBL3345162 0.69 ALDH1A1 (0.33) ALDH1A1GAA
SCHEMBL4962878 0.68 HTR2C (0.36) AKR1C3AKR1C2ALDH1A1LMNAPOLB
SCHEMBL4231362 0.68 AKR1C3 (0.38) AKR1C3AKR1C2ALDH1A1HPGDKMO
SCHEMBL4231359 0.67 AQP1 (0.45) AKR1C3AKR1C2ALDH1A1HPGDLMNA
SCHEMBL3343379 0.66 MEN1 (0.35) AKR1C3AKR1C2ALDH1A1HPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100160411-A1 BENZOXATHIINE AND BENZOXATHIOLE DERIVATIVES AND USES THEREOF WYETH (US) 2010-06-24 US disclosed
US-20100160411-A1 BENZOXATHIINE AND BENZOXATHIOLE DERIVATIVES AND USES THEREOF WYETH (US) 2010-06-24 US disclosed
US-20100160411-A1 BENZOXATHIINE AND BENZOXATHIOLE DERIVATIVES AND USES THEREOF WYETH (US) 2010-06-24 US disclosed
WO-2008052078-A2 BENZOXATHIINE AND BENZOXATHIOLE DERIVATIVES AND USES THEREOF WYETH (US) 2008-05-02 WO disclosed
WO-2008052078-A2 BENZOXATHIINE AND BENZOXATHIOLE DERIVATIVES AND USES THEREOF WYETH (US) 2008-05-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160411-A1 BENZOXATHIINE AND BENZOXATHIOLE DERIVATIVES AND USES THEREOF HTR2C, HTR3B, HTR1A AKR1C3 2002/4885AKR1C2 3205/4885ALDH1A1 2034/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.